TRPV4 and cartilage disease: In addition to providing new mechanistic understanding of this pathway, this study identifies TRPV4 as a potential therapeutic target and demonstrates that pharmaceutical activation of this protein could regulate inflammation and other IFT-dependent pathways involved in cartilage disease.